GFE and LVL Technologies strengthen supply of COVID-19 antigen tests

Frankfurt am Main; Crailsheim, March  12, 2021. – GFE and LVL Technologies today announced to strengthening their long cooperation for the current sales and support of PCL’s COVID-19 antigen rapid test, whereas both companies combine their specific core competences to strengthen the market position.

“This cooperation is a major milestone to address the increasing demands of the highly volatile COVID-19 market for continuous supply and very fast delivery processes” said Dr. Reiner Babiel, CEO at GFE.

“With our well established international logistic and supply chain we are well positioned to satisfy high logistical challenges in the current Corona pandemic.” comments Martin von Lueder, CEO at LVL.

GFE’s experiences in IVD products and regulations provides the solid basis for the regulatory compliance and a professional support of customers.

LVL’s strength in international logistics guarantees a well-established  supply chain for the increasing demands of the  antigen test market during the Corona pandemic.

Jointly the two companies want to provide superior customer experience and product availability to help successfully fighting the Corona crisis.

LVL is a privately owned company for laboratory supplies with a long history in MedTech and Pharma industries.

GFE is a wholly owned subsidiary of the three German Red Cross organisations DRK Blutspendedienst West, DRK Blutspendedienst NSTOB, and Blutspendedienst des Bayerischen Roten Kreuzes.

 

Contact:

LVL technologies GmbH & Co. KG
Theodor-Storm-Straße 17
74564 Crailsheim
T +49 7951 95613-20
www.lvl-technologies.com

GFE
Altenhöferallee 3
60438 Frankfurt am Main
T +49 69 400 5513-0
www.gfeblut.de